baber/WOPTO huggingface dataset:
Patent AU-1797183-A (AU)
Title: Magnetic-tape cassette
Inventor: SIEBEN JOANNES HENRICUS FRANCI
IPC: G11B23/04
Filed: 1983-08-15
Abstract: In a magnetic-tape cassette with a front aperture or recess at least one front cover is provided which can pivot under spring force from an open position to a closed position about a pivot which is perpendicular to the side walls of the housing of the cassette, which cover is latched in the closed position by means of at least one latching lever disposed near a side wall. The latching lever, which comprises two arms arranged in the form of an L can pivot into a latching position about a pivot which is arranged on said side wall parallel to the pivot of the front cover. The longer arm of the lever is elastically deflexible over at least a part of its length and at one end comprises a latching portion which during the pivotal movement of the lever is guided by guide means disposed near the latching portion. The shorter arm is connected at one end to the pivot of the latching lever.
Patent AU-1843501-A (AU)
Title: A building structure utilising modular building elements
Inventor: HARAMBASIC BAHRA
IPC: E04B1/04
Filed: 2000-11-29
Abstract: A building structure formed from modular building elements, which include first modular building elements (1,9) having socket beam interconnection means (2), second modular building elements (13,14,15) and socket beams (7, 11) having first modular building element interconnection means (6); whereby a socket beam (7,11) forms an interconnection with at least one first modular building element (1,9) and at least one second modular building element (13, 14, 15) associates with a socket beam (7,11) and first modular building element interconnection, a socket beam (7,11) and at least one first modular building element (1,9) and at least one second modular building element (13,14,15) forming a configuration unit, the configuration unit being repeatable one atop the other, and being repeatable in a side-by-side fashion, a first modular building element associating or abutting with adjacent first modular building elements, a second modular building elements associating or abutting with adjacent second modular building elements and a socket beam associating or abutting with adjacent socket beams.
Patent AU-1983200-A (AU)
Title: Method for the manufacturing of an aluminium-magnesium-lithium alloy product
Inventor: HASZLER ALFRED JOHANN PETER
IPC: C22C21/06
Filed: 1999-12-17
Abstract: Method for manufacturing of an aluminium-magnesium-lithium product, comprising the steps of subsequently: (a) providing an aluminium alloy consisting of (in weight %): Mg 3.0-6.0, Li 0.4-3.0, Zn up to 2.0, Mn up to 1.0, Ag up to 0.5, Fe up to 0.3, Si to 0.3, Cu up to 0.3, 0.02-0.5 selected from the group consisting of (Sc 0.010-0.40, Hf 0.010-0.25, Ti 0.010-0.25, V 0.010-0.30, Nd 0.010-0.20, Zr 0.020-0.25, Cr 0.020-0.25, Y 0.005-0.20, Be 0.0002-0.10), balance consisting essentially of aluminium and incidental elements and impurities; (b) casting the aluminium alloy into an ingot; (c) preheating the ingot; (d) hot rolling the preheated ingot to a hot worked intermediate product; (e) cold rolling the hot worked intermediate product to a rolled product in both the length and in the width direction with a total cold rolling reduction of at least 15%; (f) solution heat treating the cold rolled product in the temperature range of 465 to 565° C. for a soaking time in the range of 0.15 to 8 hours; (g) cooling the solution heat treated product from the solution heat treatment temperature to below 150° C. with a cooling rate of at least 0.2° C./sec; (h) ageing the cooled product to provide a sheet or thin plate product having a minimum yield strength of 260 MPa or more and a minimum tensile strength of 400 MPa or more in at least the L- and LT-direction, a minimum yield strength of 230 MPa or more and a minimum tensile strength of 380 MPa or more in the 45° to the L-direction, and further having a minimum T-L fracture toughness Kco of 80 MPa.{square root}m or more for 400 mm wide CCT-panels.
Patent AU-2148900-A (AU)
Title: Communications system and method with multilevel connection identification
Inventor: WINGARD DREW ERIC
IPC: G06F13/42
Filed: 1999-11-12
Abstract: A communication system (1000) is disclosed. One embodiment includes at least two functional blocks, wherein a first functional block (1002) communicates with a second functional block (1008) by establishing a connection, wherein the connection is a logical state in which data may pass between the first functional block (1002) and the second functional block (1008). Another embodiment includes a bus coupled to each of the functional blocks and configured to carry a plurality of signals. The plurality of signals includes a connection identifier that indicates a particular connection that a data transfer is part of, and a thread identifier that indicates a transaction stream that the data transfer is part of.
Patent AU-2207595-A (AU)
Title: Formulations for factor ix
Inventor: BUSH LAWRENCE
IPC: A61K47/18
Filed: 1995-04-06
Abstract: Provided by the present invention are novel compositions and methods for obtaining concentrated preparations of factor IX and formulations of factor IX suitable for storage and administration.
Patent AU-2247892-A (AU)
Title: Stable, hydrogen peroxide-containing bleaching compositions
IPC: C11D3/39
Filed: 1992-06-08
Abstract: Aqueous acidic bleaching compositions are described which comprise hydrogen peroxide and a specific class of surfactants which stabilize hydrogen peroxide.
Patent AU-2339892-A (AU)
Title: Atherectomy and angioplasty method and apparatus
IPC: A61M25/00
Filed: 1992-07-15
Abstract: A device for treating obstructions in vessels or small openings in the body, comprising a rotatable ablator tip which is guided to the obstruction in a reduced diameter configuration, expanded and rotated to remove the obstruction, and contracted to remove the device from the body. The variably expandable abrasive tip coil in one embodiment is actuated by piston means within the coil. A pair of collars is attached to the ends of the coil, and the piston effects relative longitudinal axial movement of the collars and the respective ends of the coil tip. When the ends of the coil tip are so moved, expansion and contraction of the diameter of the coil tip results. In another embodiment, the expansion tip coil is actuated by an expandable and contractible bellows disposed within the coil. In another embodiment, the expansion and contraction of the coil tip are affected by longitudinal axial movement of an internal coil attached to one end of the coil tip, within an outer coil attached to its other end. In another embodiment, expansion and contraction of the coil tip are effected by an inflatable balloon disposed within the coil tip. The balloon expansion means enlarges preferably at the central portion of the coil to make a bulge. In alternative embodiments, there is provided a combined atherectomy and balloon angioplasty device employing either a fixed or variable diameter rotatable abrasive burr, and an angioplasty balloon disposed proximal to the burr.
Patent AU-2627284-A (AU)
Title: New factor viii, coagulant polypeptides and monoclonal antibodies
Inventor: ZIMMERMAN THEODORE S
IPC: C12N5/12
Filed: 1984-03-30
Abstract: 1 or more polypeptides (I) exhibit a hand at a pt. corresp. to Mr ca. 92,000 or bands at pts. corresp. to Mr values of ca. 92,000, ca. 80,000 and ca. 79,000; of ca. 92,000, ca. 72,000 and ca. 71,000; or of ca. 92,000, ca. 80,000, ca. 79,000, ca. 72,000 and ca.71,000; when subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Coagulant has a specific conjulant activity over 1800 U/mg, the activity being shown over a continuous period of at least ca. 10 min.; and the coagulant exhibits human factor VIII:C antibody binding capacity. IgG monoclonal antibody is produced by a hybridoma formed by fusion of cells from a mouse myeloma and spleen cells from a mouse previously immunised with human factor VIII:C. Antibody reacts with human factor VIII:C and exhibits one of the following reactions. (a) Reacts with polypeptides of Mr 92,000, Mr 180,000 or greater and Mr 54,000 and does not react with those of Mr 44,000, 71,000, 72,000, 79,000, 80,000; (b) reacts with polypeptides of Mr 92,000, 100,000 or greater and 44,000 and does not react with those of Mr 54,000, 71,000, 72,000, 79,000, 80,000; (c) reacts with polypeptides of Mr 79,000, 80,000 and 100,000 or greater and does not react with those of Mr 44,000, 54,000, 71,000, 72,000, 92,000; (d) reacts with polypeptides of Mr 108,000 or greater but not with those of Mr below 108,000.
Patent AU-2756300-A (AU)
Title: Recombinant expression of heterologous nucleic acids in protozoa
Inventor: GAERTIG JACEK
IPC: A61K39/00
Filed: 2000-02-04
Abstract: The ciliated protozoan Tetrahymena exemplifies a recombinant system for the expression of heterologous nucleic acids, preferably on the plasma membrane surface. Integration of a heterologous nucleic acid into the  beta -tubulin gene, BTU1, of a paclitaxel-sensitive T. thermophila mutant that possesses btul-1K350M  beta -tubulin allele allows screening for transformants using negative selection, as transformants have restored paclitaxel resistance. Transgenic ciliated protozoa of the invention can serve as live vaccines. For example, transgenic Tetrahymena expressingIchthyophthirius multifiliis i-antigen protein on their surface are effective vehicles for vaccination of freshwater fish against infection by I. multifiliis.
Patent AU-2816301-A (AU)
Title: Nucleotide sequences coding for the dapC gene and process for the production of L-lysine
Inventor: MOCKEL BETTINA
IPC: C12N1/21
Filed: 2001-03-21
Abstract: Isolated polynucleotide comprises the dapC gene from coryneform bacteria, is new. Isolated polynucleotide (I): (i) is at least 70% identical with a sequence that encodes a protein (II) comprising a 367 amino acid (aa) sequence as given in the specification; (ii) encodes a polypeptide at least 70% identical with (II); (iii) is complementary to (i) or (ii); or (iv) contains at least 15 consecutive nucleotides from (i)-(iii). Independent claims are also included for the following: (1) a vector (III) containing (I); (2) a coryneform bacterial host cell (VI) that contains (III), or has the zwaI gene; (3) the production of L-aa, especially L-lysine, by growing bacteria in which at least the dapC gene is amplified; (4) DNA (V), from coryneform bacteria which encodes an N-succinyl-aminoketopimelate-transaminase and whose sequence is as (2) except that 209Pro is replaced by some other aa; and (5) coryneform bacteria (V) containing (V).
Patent AU-2821197-A (AU)
Title: Control for an electric heating device for providing consistent heating results
Inventor: ALLARD JOHN
IPC: A47J37/01
Filed: 1997-05-01
Abstract: A control for an electric heating device for adjusting the duration of the device's heating cycle in order to effectively compensate for variations in the operating voltage supplied to the device. The control includes a means for adjusting the duration of the heating cycle, wherein the adjustment means generates a control voltage for controlling the duration of the heating cycle that is a dynamic function of the magnitude of the operating voltage.
Patent AU-2841092-A (AU)
Title: Method for the reduction of allyl alcohols
IPC: C07D307/935
Filed: 1992-11-17
Abstract: A method for the reduction of an allyl alcohol-type compound specific to its allylic hydroxyl group, which is carried out without any side reactions, such as reduction of other parts of the compound and allylic rearrangement, which method comprises treating said compound with a trialkylsilane in the presence of A1X3, wherein X is a halogen atom.
Patent AU-3080192-A (AU)
Title: Peroral administration form for peptidic medicaments, in particular insulin
IPC: A61K9/50
Filed: 1992-12-04
Abstract: A peroral administration form for peptidic medicaments contains the peptidic medicament, in particular insulin, distributed in a gelatine or gelatine derivate matrix, besides usual pharmaceutical excipients and additives. By selecting an appropriate gelatine, the medicament is released in the small or large intestine, so that it is no longer enzymatically decomposed by peptidases.
Patent AU-3172699-A (AU)
Title: Fin tube heat exchanger
Inventor: KANG HIE-CHAN
IPC: F28F1/32
Filed: 1999-04-09
Abstract: A fin tube heat exchanger includes plate-shaped elongated fin members spaced at regular intervals, in parallel with one another. Each fin member has a fin base, through-holes in two rows in a longitudinal direction of the fin member, and raised portions with legs. Heat exchanger tubes are inserted into the through-holes. Each fin member has flat areas at a front and middle regions of a front half and a middle region of a rear half. The raised portion disposed at a rear region of the front half and a front region of the rear half has the legs inclined by a predetermined angle with respect to a traverse centerline which passes through the center of an adjacent through-hole of the front row. The distance from the centerline generally increases with a direction of airflow. A larger volume of air can be directed toward the vicinity of the tubes of the rear row. Each fin member has a front edge and a rear edge. The front edge has protruding portions and recessed portions and the rear edge has protruding portions and recessed portions. The protruding portion of the front edge substantially corresponds to the recessed portion of the rear edge disposed on the same centerline.
Patent AU-3188999-A (AU)
Title: Development of human monoclonal antibodies and uses thereof
Inventor: TRAKHT ILYA
IPC: C07K16/00
Filed: 1999-03-18
Abstract: The present invention provides a heteromyeloma cell other than B6B11, capable of producing a trioma cell when fused with a human lymphoid cell, wherein the trioma cell is capable of producing a tetroma cell capable of producing a monoclonal antibody having specific binding affinity for an antigen, when fused with a second human lymphoid cell, the second human lymphoid cell being capable of producing antibody having specific binding affinity for the antigen. The invention provides a trioma cell fusion partner which does not produce any antibody obtained by fusing a hetermomyeloma cell which does not produce any antibody with a human lymphoid cell. The invention provides a tetroma cell capable of producing a monoclonal antibody having specific binding affinity for an antigen obtained by fusing a trioma cell which does not produce any antibody with a human lymphoid cell capable of producing antibody having specific binding affinity for the antigen. The invention provides a method of producing a monoclonal antibody specific for an antigen associated with a condition. The invention provides a method of identifying an antigen associated with a condition using the trioma fusion partner. The invention provides a method of diagnosing a condition using the trioma fusion partner. The invention provides a method for preventing a condition. Compositions and therapeutic compositions are also provided, using monoclonal antibodies produced using the trioma fusion partner.
Patent AU-3189395-A (AU)
Title: 2,7-substituted octahydro-1h-pyrido{1,2-a}pyrazine derivatives
Inventor: DESAI KISHOR A
IPC: A61P25/16
Filed: 1995-08-24
Abstract: PCT No. PCT/IB95/00689 Sec. 371 Date Mar. 26, 1997 Sec. 102(e) Date Mar. 26, 1997 PCT Filed Aug. 24, 1995 PCT Pub. No. WO96/10571 PCT Pub. Date Apr. 11, 1996Substituted pydrido[1,2-a]pyrazines of general formula I wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, C=O, CHOH, or -(CR3R4) and n is 0-2 as well as precursors thereto are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment of disorders of the dopamine system.    <IMAGE>  I
Patent AU-3237000-A (AU)
Title: Phthalamide-lanthanide complexes for use as luminescent markers
Inventor: RAYMOND KENNETH N
IPC: C07C235/60
Filed: 2000-02-18
Abstract: The present invention provides luminescent lanthanide metal chelates comprising a metal ion of the lanthanide series and a complexing agent comprising at least one phthalamidyl moiety. Also provided are probes incorporating the phthalamidyl ligands of the invention and methods utilizing the ligands of the invention and probes comprising the ligands of the invention.
Patent AU-3524997-A (AU)
Title: System for transmitting digital video signals by way of a telecommunications network, as well as device
Inventor: SMIT MICHEL JEAN PAUL
IPC: H04N7/18
Filed: 1997-08-22
Abstract: Known systems for recording traffic offences comprise a device and a security camera which, either by way of a constantly present telecommunication connection transmits the digital video signals to an incident room, or is provided with a roll of film which should be regularly replaced. By providing the device with a memory for storing video images and with a threshold-value circuit for, in the event of exceeding, generating an indication signal, with a telecommunication connection being set up only in response to the indication signal, the video images stored in the memory, after having been read out, may be fed to the output and transmitted to an incident room by way of the telecommunication connection set up. In this case, therefore, the threshold-value circuit is used to take a certain initiative, such as the indication that a telecommunication connection should be set up, with said setting up being capable of taking place either from the device or from a network. <IMAGE>
Patent AU-3580289-A (AU)
Title: Production of a deoxyribonucleoside
Inventor: NAYLOR LINDA ANNE
IPC: C12P17/12
Filed: 1989-05-30
Abstract: A process for the fermentative production of the deoxyribonucleoside thymidine and/or its corresponding base thymine by aerobically cultivating a strain of the genus Brevibacterium, in particular one of the strains NCIMB 40014, 40117 and 40116. The produced thymidine may be used as an intermediate in the production of azidothymidine an active ingredient in a composition for use in the treatment of auto imune deficiency syndrome (AIDS). Biologically pure cultures of strain NCIMB 40014 and variants and mutants derived therefrom are claimsed per se.
Patent AU-3624399-A (AU)
Title: Microfluidic device
Inventor: LARSSON ANDERS
IPC: C12M1/20
Filed: 1999-05-07
Abstract: A microfluidic device adapted such that the flow of fluids within the device is controlled by different surfaces of the device having different surface characteristics. Preferably the device comprises a substrate not formed from a hydrated oxide material.
Patent AU-3635384-A (AU)
Title: Chitosan 6-sulfate
Inventor: NAGGI ANAMARIA
IPC: C08B37/08
Filed: 1984-12-06
Abstract: 1. Claims for contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Chitosan 6-sulfate of formula  see diagramm : EP0148057,P4,F2 wherein n is an integer from 4 to 6000 and A represents a hydrogen atom or, in a number of up to 30% of the n subunits, an acetyl group or a salt thereof with an inorganic or organic acid or with an inorganic or organic bases or an internal salt thereof. 1. Claims for the contracting State : AT Process for the preparation of a chitosan 6-sulfate of formula  see diagramm : EP0148057,P5,F1  wherein n is an integer from 4 to 6000 and A represents a hydrogen atom or, in a number of up to 30% of the n subunits, an acetyl group or a salt thereof with an inorganic or organic acid or with an inorganic or organic bases or internal salts thereof, characterized in that a chitosan is added, at the temperature of -20 to +40 degrees C to a mixture of sulphuric acid and chlorosulfonic acid in a ratio of 4 : 1 to 1 : 4 and in that after a period of 5 mins. to 2 hours, the product is isolated as an alkali metal salt or converted into the acid form or in another salt.
Patent AU-3636499-A (AU)
Title: Golf club and bag security system
Inventor: FRENCH JOHN R
IPC: A63B55/00
Filed: 1999-03-25
Abstract: One aspect of the invention is directed to a security system for a golf bag with a set of golf clubs. The invention may utilize a small, lightweight control subsystem which is easily mounted on a golfer's existing golf bag to protect both the golf clubs and the bag from theft. In another embodiment, the golf security system may be built into or integrated with a golf bag. The golf security system utilizes the electronic, programmable control subsystem which is designed to prohibit false alarms and senses minute unauthorized changes in the electromagnetic field defined by a detection loop. The control subsystem may include an input device such as a keypad, an electronic key, or other similar input means to arm and disarm the system. In one embodiment, a tag having high magnetic permeability is attached to golf clubs having non-metallic shafts.
Patent AU-3638101-A (AU)
Title: Customizable fixture for patient positioning
Inventor: FRANKLIN RONALD J
IPC: A61B6/12
Filed: 2000-10-27
Abstract: A customized positioning fixture is fabricated specifically for a patient the purpose of positioning a portion, or all, of the patient's body relative to a medical apparatus. The customized positioning fixture is fabricated such that the relative position of the patient to the medical apparatus is predetermined before a procedure is performed on the patient using the apparatus. The positioning fixture is fabricated using a computer-aided or an automated computer-controlled process according to data determined for that patient, for example, using a rapid prototyping and tooling (RPT) technique. In some embodiments, the positioning fixture is designed to be repeatedly removed and reattached to the patient, thereby allowing the patient to be repeatedly precisely re-positioned in the medical device in separated sessions. A second positioning fixture can also be fabricated so that the patient can be positioned relative to a second apparatus in a way that the patient's position in the two different apparatuses is related in a desired manner.
Patent AU-3687795-A (AU)
Title: Cover foil with heat-activated layer
Inventor: REINDERS JOHANNES ANTONIUS MAR
IPC: B32B27/08
Filed: 1995-09-22
Abstract: PCT No. PCT/NL95/00318 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09928 PCT Pub. Date Apr. 4, 1996The invention provides a light-transmitting cover foil intended to be arranged adheringly to a surface, for instance the surface of a carrier plate, optionally bearing information such as letters, numbers, images or the like, which foil consists of a laminate comprising: a first layer plastically deformable only at a relatively high first temperature, for instance in the range of 120 DEG  C.-200 DEG  C. and comprising for instance polycarbonate, PMMA, PVC, ABS, PP, PE, which first layer is provided before, during or after joining together to the other layers with a structure, for instance a texture and/or pattern pressed out of its main surface by exerting pressure and increasing temperature to at least the said first temperature, for instance by applying a heated profile roller; a second layer adhered thereto consisting of a dimensionally stable carrier layer comprising for instance polycarbonate, PMMA, PVC, polyester/PET, ABS; and a third layer adhered thereto which is meltable and thus thermally-activated at a relatively low second temperature, for instance in the range of 50 DEG  C.-90 DEG  C. and which consists of a hot-melt layer or glue layer, comprising for instance EVA, EEA, EBA, EMA, GBA or other low-melting plastics including polyolefins and copolymer esters, polyacetate esters, softened PVCs; which said layers are mutually connected by adhesive agents, for instance by making use of coextrusion.